Both non-lean and lean individuals with metabolic dysfunction-associated steatotic liver disease are susceptible to long-term liver and cardiovascular disease outcomes, according to data presented at ...
CKD screening at age 55, combined with SGLT2 inhibitors, reduces kidney failure incidence and improves life expectancy across racial and ethnic groups. Non-Hispanic Black adults experience the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback